Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China

Chinese Academy of Medical Sciences, Fuwai Hospital1,906 enrolled

Overview

Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD). However, the exact prevalence is not known in China. COPD patients with anxiety and depression tend to have more severe symptoms and worse prognosis, but the related evidences are not strong enough. The study aim to investigate the prevalence and long-term outcome of anxiety and depression in COPD.

Study Type

OBSERVATIONAL

Enrollment

1,906

Conditions

COPD Anxiety Depression

Eligibility

Sex: ALLMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Stable chronic obstructive pulmonary disease (COPD) patients Exclusion Criteria: * Patients with bronchial asthma or other severe pulmonary diseases or having received pulmonary surgery in 6 months * Patients with tumor history during past 5 years * Patients with COPD exacerbations during past 4 weeks * Participants in clinical trials * Patients in pregnancy or breastfeeding * Patients unable to complete questionaire independently * Patients older than 80 years old * Patients receiving long-term domiciliary oxygen therapy

Locations (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

RECRUITING

Outcomes

Primary Outcomes

moderate and severe COPD exacerbations

total times

Time frame: 3 years

Secondary Outcomes

All-cause mortality

mortality in %

Time frame: 3 years

Central Contacts

Jiangna Han, MD

CONTACT

13520053104 13520053104@139.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.